ArticleBMJ open2022

Real-world effectiveness of casirivimab and imdevimab among patients diagnosed with COVID-19 in the ambulatory setting: a retrospective cohort study using a large claims database.

Mohamed Hussein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.